NCT03307395View on ClinicalTrials.gov

Middle Meningeal Artery Embolization for Treatment of Chronic Subdural Hematoma

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 31, 2017

Primary Completion Date

July 30, 2018

Study Completion Date

July 30, 2018

Conditions
Chronic Subdural Hematoma
Interventions
PROCEDURE

Middel Meningeal Artery Embolization

Blood supply to the subdural hematoma via the middle meningeal artery is interrupted.

Trial Locations (1)

10065

Weill Cornell Medical College, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT03307395 - Middle Meningeal Artery Embolization for Treatment of Chronic Subdural Hematoma | Biotech Hunter | Biotech Hunter